Collaboration Partners
Optimum Patient Care (OPC) Global
- Co-sponsorship, Project Management and Delivery
- Co-funding the initial setup of ISAR (50%)
- Data standardisation, eCRF, processing, hosting and guardianship
OPC Global: A research organisation with 10 years of experience. OPC Global Has successfully collaborated with renowned research institutes globally contributing towards the delivery of over 48 research projects and publications. It is an contributor of OPCRD academic research and collaborations.
David Price – Chief Scientist & Global Engagement
david@opri.sg
Victoria Carter – Sponsor Engagement Lead
victoria@optimumpatientcare.org
Chris Price – Legal & Contracting Lead
chris@optimumpatientcare.org
Ruth Murray – Publication Lead
Nevaashni Eleangovan – Operations Lead
neva@optimumpatientcare.org
Anthony Newell – Research Analytics Manager
anthony@optimumpatientcare.org
Brooklyn Stanley – Data Lead
brooklyn@optimumpatientcare.org
Nasloon Ali – Researcher
nasloon@optimumpatientcare.org
Sarah Burkill – Researcher
Ghislaine Scelo – Researcher
Joash Tan – Academic Assistant
Amy Pickering – Country Coordinator
amy.pickering@optimumpatientcare.org
Julie-Anne Cook – Project Administrator
julie-anne@optimumpatientcare.org
Juntao Lyu – Data Analyst
juntao@optiumumpatientcare.org
Indu Joshi – Junior Data Analyst
Matthew Lee – Database Administrator
matthewlee@optimumpatientcare.org
Choy Lye Chei – Japan Coordinator
Laura Williams – Director’s Personal Assistant
laura.williams@optimumpatientcare.org
Helen Kaminska – Legal Counsel
helenck@optimumpatientcare.org
Sophie Harriman – Legal Counsel
sophie.harriman@optimumpatientcare.org
Email: info@optimumpatientcare.org
AstraZeneca
- Co-sponsorship
- Co-funding the initial set up of ISAR
AstraZeneca: A global biopharmaceutical business delivering medicines to patients through innovative science and excellence in development and commercialisation.
Trung N. Tran – Senior Director of Epidemiology
Peter Barker – Statistical Science Director
Rohit Katial – Global Medical Head, Fasenra
Neil Martin – Head of Tezepelumab
Observational and Pragmatic Research Institute (OPRI)
OPRI: Real world database research organization working to improve the understanding of risk-factors for poorly-controlled disease, the effectiveness of drugs, devices and patient management strategies in real life. OPRI ultimately aims to inform healthcare professionals on how to integrate and optimize these factors to drive better disease management.
Respiratory Effectiveness Group (REG)
- Academic partner
- Forum for discussion (REG Summit, Severe Asthma & Biomarkers Working Group)
- Anonymized Data & Ethics Protocol Transparency (ADEPT) committee
REG: A not-for-profit investigator-led academic initiative comprising of over 420 respiratory/allergy experts globally collaborating on independent, academic real-life and comparative effectiveness research in respiratory medicine.
Michael Walker – Chief Operating Officer
Sinthia Bosnic-Anticevich – President
Dermot Ryan – Director
Independent Governing Bodies
| ISAR Steering Committee |
|
| Respiratory Effectiveness Group (REG) |
|
| ADEPT Committee |
|
| Operational Committee |
|